~~<i id='66B010B326'><strike id='66B010B326'><tt id='66B010B326'><pre id='66B010B326'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：leisure time 2025-08-26 01:21:36 - browse：7153

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Problems with a popular proposal to regulate AI in health care

hotspot

leisure time

entertainment

hotspot

entertainment

leisure time

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

WSS

Cano Health’s bankruptcy is a warning for Medicare Advantage

What’s missing from the debate over nursing home staff minimums

Jerome Adams on the need for new antivirals for Covid

Medicare details structure of new drug price negotiation program

340B reform proposal comes out of Senate working group

Readout Newsletter: Amgen, Regeneron, BGI Group and more

focus

hotspot

hotspot

Hollywood unions extend contract negotiations for actors

Gene therapy for Afghan refugees’ infant will be fully covered

Tori Bowie and the unacceptable rates of Black maternal death

Top private equity targets in 2023: cardiology, clinical trials, lasers

Peter Hotez and the public health issue of online harassment

Devoted Health’s losses in Medicare Advantage persist

Guidelines to prevent youth baseball injuries need more muscle

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Moonlake's readout produced a cash windfall. Risks remain

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

leisure time

AstraZeneca stays mum on Medicare drug pricing negotiations

Virginia high school admissions case could be legal follow

The Biogen Aduhelm mess could happen again

At least 13 dead in Texas as scorching temps continue

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

entertainment

hotspot

entertainment

leisure time